NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.

Oncotarget · 2016 · PMC4872748 · PMID 26735180

Europe PMC DOI

hedged sentences

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

reached borderline significancep = 0.088so close (0.05 < p ≤ 0.1)

Tumor size on day 16 reached borderline significance for values expressed as percentage ( p = 0.088, two-sided t -test) comparing the 0.5 mg/kg bw groups of both experiments with the saline controls.

also in 370 other papers

showed a trendno p-value reported

Experiments with M21 melanoma xenografts (Figure 9B ) showed a trend for tumor growth retardation by tTF 218 -TAA either in the native or in a randomly TMS(PEG) 12 -PEGylated form.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

However, this did not reach statistical significance, since experiments had to be stopped due to tumor size and animal regulation.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.